Literature DB >> 29992488

AhR activation protects intestinal epithelial barrier function through regulation of Par-6.

Kun Yu1, Yuanhang Ma1, Zhicao Zhang1, Xin Fan1, Teming Li1, Liangzi Li1, Weidong Xiao1, Yujiao Cai1, Lihua Sun1, Pengyuan Xu2, Min Yu3, Hua Yang4.   

Abstract

The Par complex (Par-6/Par-3/aPKC) plays a key role in the maintenance of the intestinal barrier function through the regulation of epithelial junction formation. The aryl hydrocarbon receptor (AhR) has been shown to be an important regulator for intestinal homeostasis. In this study, we investigated the role of the AhR activation on the regulation of Par complex. AhR activation by 6-formylindolo (3,2-b) carbazole (FICZ) represses the abnormal expression of the Par complex in a mouse model of dextran sulphate sodium (DSS)-induced colitis. In T84 cells, overexpression of Par-6 causes intestinal barrier dysfunction. Lipopolysaccharide (LPS)-induced intestinal epithelial barrier dysfunction and increase in Par-6 expression was prevented by AhR activation. However, FICZ did not alter the expression of Par-3 or aPKC. Furthermore, AhR activation alleviated LPS-induced increase of Par-6 through repressing the expression of activating protein-2γ (Ap-2γ). These results reveal the protective effects of AhR activation on LPS induced disruption of intestinal epithelial barrier function through suppressing the expression of Par-6 expression. Our findings provide novel insights into the protective role of AhR in intestinal barrier function.

Entities:  

Keywords:  Ap-2γ; Aryl hydrocarbon receptor; Inflammatory bowel disease; Intestinal epithelial barrier; Par-6

Mesh:

Substances:

Year:  2018        PMID: 29992488     DOI: 10.1007/s10735-018-9784-1

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  31 in total

1.  PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex.

Authors:  T Yamanaka; Y Horikoshi; A Suzuki; Y Sugiyama; K Kitamura; R Maniwa; Y Nagai; A Yamashita; T Hirose; H Ishikawa; S Ohno
Journal:  Genes Cells       Date:  2001-08       Impact factor: 1.891

Review 2.  Structural organization of the tight junctions.

Authors:  Luca Paris; Laura Tonutti; Cristina Vannini; Gianfranco Bazzoni
Journal:  Biochim Biophys Acta       Date:  2007-08-24

Review 3.  Regulation of tight junction permeability by intestinal bacteria and dietary components.

Authors:  Dulantha Ulluwishewa; Rachel C Anderson; Warren C McNabb; Paul J Moughan; Jerry M Wells; Nicole C Roy
Journal:  J Nutr       Date:  2011-03-23       Impact factor: 4.798

4.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

5.  Assembly of epithelial tight junctions is negatively regulated by Par6.

Authors:  Lin Gao; Gérard Joberty; Ian G Macara
Journal:  Curr Biol       Date:  2002-02-05       Impact factor: 10.834

Review 6.  Mechanisms of polarity protein expression control.

Authors:  Syed Mukhtar Ahmed; Ian G Macara
Journal:  Curr Opin Cell Biol       Date:  2016-04-16       Impact factor: 8.382

7.  Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor.

Authors:  Francisco J Quintana; Alexandre S Basso; Antonio H Iglesias; Thomas Korn; Mauricio F Farez; Estelle Bettelli; Mario Caccamo; Mohamed Oukka; Howard L Weiner
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

8.  Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway.

Authors:  Bin Han; Baifa Sheng; Zhicao Zhang; Aimin Pu; Jiuheng Yin; Qimeng Wang; Kunqiu Yang; Lihua Sun; Min Yu; Yuan Qiu; Weidong Xiao; Hua Yang
Journal:  Shock       Date:  2016-09       Impact factor: 3.454

9.  Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.

Authors:  Peter Suenaert; Veerle Bulteel; Liesbeth Lemmens; Maja Noman; Benny Geypens; Gert Van Assche; Karel Geboes; Jan L Ceuppens; Paul Rutgeerts
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

10.  Impaired intestinal mucosal barrier upon ischemia-reperfusion: "patching holes in the shield with a simple surgical method".

Authors:  Olivér Rosero; Péter Ónody; Tibor Kovács; Dávid Molnár; Gábor Lotz; Szilárd Tóth; Zsolt Turóczi; András Fülöp; Dávid Garbaisz; László Harsányi; Attila Szijártó
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

View more
  5 in total

1.  Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s.

Authors:  Yan-Yang Li; Xiao-Jing Wang; Yu-Lin Su; Qing Wang; Shao-Wei Huang; Zeng-Feng Pan; Yan-Ping Chen; Jun-Jie Liang; Mei-Ling Zhang; Xue-Qian Xie; Zhi-Yun Wu; Jin-Yan Chen; Lian Zhou; Xia Luo
Journal:  Acta Pharmacol Sin       Date:  2021-10-20       Impact factor: 7.169

Review 2.  Aryl hydrocarbon receptor: Its roles in physiology.

Authors:  Ziyue Kou; Wei Dai
Journal:  Biochem Pharmacol       Date:  2021-01-28       Impact factor: 5.858

3.  Prenylated xanthones from mangosteen (Garcinia mangostana) activate the AhR and Nrf2 pathways and protect intestinal barrier integrity in HT-29 cells.

Authors:  Restituto Tocmo; Bryan Le; Amber Heun; Jan Peter van Pijkeren; Kirk Parkin; Jeremy James Johnson
Journal:  Free Radic Biol Med       Date:  2020-12-09       Impact factor: 7.376

4.  AhR activation defends gut barrier integrity against damage occurring in obesity.

Authors:  Bárbara G Postal; Sara Ghezzal; Doriane Aguanno; Sébastien André; Kevin Garbin; Laurent Genser; Edith Brot-Laroche; Christine Poitou; Hédi Soula; Armelle Leturque; Karine Clément; Véronique Carrière
Journal:  Mol Metab       Date:  2020-04-28       Impact factor: 7.422

Review 5.  Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases.

Authors:  Alkeiver S Cannon; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.